BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9643585)

  • 1. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
    Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
    Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escherichia coli MTC, a NADPH cytochrome P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450: comparison of three types of expression systems.
    Kranendonk M; Fisher CW; Roda R; Carreira F; Theisen P; Laires A; Rueff J; Vermeulen NP; Estabrook RW
    Mutat Res; 1999 Feb; 439(2):287-300. PubMed ID: 10023085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli MTC, a human NADPH P450 reductase competent mutagenicity tester strain for the expression of human cytochrome P450 isoforms 1A1, 1A2, 2A6, 3A4, or 3A5: catalytic activities and mutagenicity studies.
    Kranendonk M; Carreira F; Theisen P; Laires A; Fisher CW; Rueff J; Estabrook RW; Vermeulen NP
    Mutat Res; 1999 Apr; 441(1):73-83. PubMed ID: 10224324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay.
    Aryal P; Terashita T; Guengerich FP; Shimada T; Oda Y
    Environ Mol Mutagen; 2000; 36(2):121-6. PubMed ID: 11013410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stimulatory role of human cytochrome b5 in the bioactivation activities of human CYP1A2, 2A6 and 2E1: a new cell expression system to study cytochrome P450 mediated biotransformation.
    Duarte MP; Palma BB; Gilep AA; Laires A; Oliveira JS; Usanov SA; Rueff J; Kranendonk M
    Mutagenesis; 2005 Mar; 20(2):93-100. PubMed ID: 15728263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of recombinant human cytochrome P450 1A2 in Escherichia coli bacterial mutagenicity tester strain.
    Chun YJ
    Arch Pharm Res; 1998 Jun; 21(3):305-9. PubMed ID: 9875448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Escherichia coli DJ4309 expressing human P450 1A2 in mutagenicity testing of complex food mixtures.
    Constable A; Varga N; Josephy PD; Guy P; Turesky RJ
    Mutat Res; 1999 Jun; 442(2):79-87. PubMed ID: 10393276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flavonoids inhibit genetic toxicity produced by carcinogens in cells expressing CYP1A2 and CYP1A1.
    Lautraite S; Musonda AC; Doehmer J; Edwards GO; Chipman JK
    Mutagenesis; 2002 Jan; 17(1):45-53. PubMed ID: 11752233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli BTC, a human cytochrome P450 competent tester strain with a high sensitivity towards alkylating agents: involvement of alkyltransferases in the repair of DNA damage induced by aromatic amines.
    Duarte MP; Palma BB; Laires A; Oliveira JS; Rueff J; Kranendonk M
    Mutagenesis; 2005 May; 20(3):199-208. PubMed ID: 15843388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase.
    Aryal P; Yoshikawa K; Terashita T; Guengerich FP; Shimada T; Oda Y
    Mutat Res; 1999 Jun; 442(2):113-20. PubMed ID: 10393280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli.
    Josephy PD; Evans DH; Parikh A; Guengerich FP
    Chem Res Toxicol; 1998 Jan; 11(1):70-4. PubMed ID: 9477228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of enzyme activities and cofactors involved in bioactivation and bioinactivation of chemical carcinogens in the tester strains Escherichia coli K12 MX100 and Salmonella typhimurium LT2 TA100.
    Kranendonk M; Commandeur JN; Laires A; Rueff J; Vermeulen NP
    Mutagenesis; 1997 Jul; 12(4):245-54. PubMed ID: 9237769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of the mutagenicity of aromatic amines by protein kinases and phosphatases. I. The protein phosphatase inhibitors okadaic acid and ortho-vanadate drastically reduce the mutagenicity of aromatic amines.
    Oesch-Bartlomowicz B; Arens HJ; Richter B; Hengstler JG; Oesch F
    Arch Toxicol; 1997; 71(10):601-11. PubMed ID: 9332696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
    Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
    Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen peroxide supports human and rat cytochrome P450 1A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase.
    Anari MR; Josephy PD; Henry T; O'Brien PJ
    Chem Res Toxicol; 1997 May; 10(5):582-8. PubMed ID: 9168257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
    Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
    Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines.
    Yueh MF; Nguyen N; Famourzadeh M; Strassburg CP; Oda Y; Guengerich FP; Tukey RH
    Carcinogenesis; 2001 Jun; 22(6):943-50. PubMed ID: 11375903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of aflatoxin B1 by expression of human CYP1A2 polymorphisms in Saccharomyces cerevisiae.
    Fasullo M; Smith A; Egner P; Cera C
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Feb; 761():18-26. PubMed ID: 24472830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MX100, a new Escherichia coli tester strain for use in genotoxicity studies.
    Kranendonk M; Pintado F; Mesquita P; Laires A; Vermeulen NP; Rueff J
    Mutagenesis; 1996 Jul; 11(4):327-33. PubMed ID: 8671756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.